Canada markets closed

Nymox Pharmaceutical Corporation (NYM.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
1.75000.0000 (0.00%)
At close: 08:29PM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 148.71M
Enterprise Value 143.63M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)36.11
Enterprise Value/Revenue -28.73k
Enterprise Value/EBITDA -13.21

Trading Information

Stock Price History

Beta (5Y Monthly) 0.32
52-Week Change 3-6.91%
S&P500 52-Week Change 324.49%
52 Week High 32.7800
52 Week Low 31.0700
50-Day Moving Average 31.7345
200-Day Moving Average 31.5246

Share Statistics

Avg Vol (3 month) 338
Avg Vol (10 day) 3N/A
Shares Outstanding 583.73M
Implied Shares Outstanding 6N/A
Float 853.09M
% Held by Insiders 142.05%
% Held by Institutions 10.05%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)36,280.00%

Management Effectiveness

Return on Assets (ttm)-59.51%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)-5k
Revenue Per Share (ttm)-0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -1.98M
Net Income Avi to Common (ttm)-4.87M
Diluted EPS (ttm)-0.1740
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)76k
Total Cash Per Share (mrq)0
Total Debt (mrq)11k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.25
Book Value Per Share (mrq)-0.02

Cash Flow Statement

Operating Cash Flow (ttm)-4.41M
Levered Free Cash Flow (ttm)-726.55k